Kingmed Diagnostics(SH:603882) Zheng Quan Ri Bao Wang·2025-07-17 12:46Core Viewpoint - The inclusion of Guangzhou Kingmed Diagnostics Group Co., Ltd. in the first batch of trusted data space innovation development pilot projects signifies national recognition of its practices in medical data security and application, addressing the challenges of data sharing in the healthcare industry [1][2]. Group 1: Company Overview - Kingmed Diagnostics has over 30 years of experience in the medical testing industry, possessing a core asset of more than 3 billion medical testing data and a service network covering over 90% of the Chinese population [2]. - The company serves more than 23,000 medical institutions, positioning itself as a pioneer in the marketization of medical data elements [2]. Group 2: Industry Impact - The pilot project aims to break the long-standing data isolation issues in the medical industry, enhancing the value of data as a production factor and promoting compliant circulation of medical data [2]. - The trusted data space is viewed as a "data safe house," allowing different data providers to share data securely, which is crucial for the healthcare sector [1][2]. Group 3: Future Strategy - Kingmed Diagnostics plans to leverage the trusted data space as a key infrastructure for its "data + AI" strategy, aiming to create a second growth curve driven by data elements [2]. - The company intends to enhance the platform attributes and public service functions of the data space over the next five years, attracting more hospitals, doctors, and individuals to participate [2].